Beauty Health beats Q2, raises FY2025 forecast; revenue $78.2M, adj. EBITDA $13.9M

SkinHealth Systems Inc.

2025-Q2 EPS reported -$0.02 vs consensus -$0.05 ▲ beat (+62.9%)

Q2 net sales $78.2M (down 13.7% YoY but beat expectations); net income $19.7M vs $0.2M.
Adjusted EBITDA surged to $13.9M from $(5.2)M; adjusted gross margin 65.9% (vs 49.4%).
Raised full-year 2025 outlook on strong consumables growth and cost discipline.
Active device install base 35,193 (+5% YoY); consumables 71% of revenue at $55.8M.
Innovation engine delivering: HydraFillic with Pep9 Booster launched successfully.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.